CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (114,206)	$ (37,030)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,475	11,170
Amortization of inventory step-up	5,315	0
Inventory impairment charges	478	1,192
Share-based compensation	36,571	30,845
Amortization of discount and cost of issuance of debt	747	226
Bad debts	0	24
(Gain) loss from change in fair value of warrants	6,626	(48,595)
Gain from change in fair value of contingent considerations and acquisition-related holdbacks	(4,208)	(3,546)
(Gain) loss from change in fair value of currency forward contract	298	(211)
Deferred City Semi compensation	0	203
Deferred tax liabilities	(8,731)	1,532
Amortization of right-of-use assets	1,917	1,463
Changes in operating assets and liabilities:
Accounts receivable	(13,048)	(8,854)
Inventory	(12,489)	(2,406)
Accounts payable	(654)	2,945
Accrued expenses and other current liabilities	(1,284)	1,587
Accrued payroll liabilities	110	(843)
Deferred revenue	(1,070)	93
Prepaid and other current assets	(13,896)	(6,129)
Operating lease liabilities	(1,670)	(1,159)
Other long-term liabilities	4,742	(1,322)
Net cash used in operating activities	(87,977)	(58,815)
Cash flows from investing activities:
Purchases of property and equipment	(8,580)	(4,508)
Business combinations, net of cash acquired	(94,989)	(8,705)
Net cash used in investing activities	(103,569)	(13,213)
Cash flows from financing activities:
Proceeds from issuance of common stock/At-the-market offering	51,998	12,273
Offering costs for the issuance of common stock/At-the-market offering	0	(273)
Proceeds from issuance of short-term debt obligations	1,717	1,059
Payments on debt obligations	(12,514)	(1,404)
Payments on financed software	(7,037)	(3,224)
Deferred payments on business combination	0	(5,000)
Payments of City Semi deferred compensation	0	(1,000)
Proceeds from exercise of stock options	31	100
Net cash provided by financing activities	34,195	2,531
Effect of exchange rate changes on cash and cash equivalents	(3,880)	804
Net decrease in cash and cash equivalents	(161,231)	(68,693)
Cash, cash equivalents and restricted cash at beginning of period	321,879	219,464
Cash, cash equivalents and restricted cash at end of period	160,648	150,771
Supplemental disclosure of cash flow information:
Cash paid for interest	3,807	218
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	243	275
Fair value of common stock issued for business combination	128,182	0
Fair value of common stock issuable for business combination	23,479	0
Contingent consideration for business combination	86,297	8,204
Accrual for purchase consideration for business combination	$ 4,264	$ 9,674